AR expression has been reported in over 70% of estrogen receptor (ER)-positive (ER+) breast cancers, approximately 60% of HER2-positive (HER2+) breast cancers, and 30% to 45% of triple-negative breast cancers (TNBCs) [11–15]. The gene discussed is AR; the disease is breast cancer.